English (United Kingdom)

https://curated-unify.zendy.io/wp-json/zendy-region/v1/featured_content/oa?rat=en

https://curated-unify.zendy.io/wp-json/zendy-region/v1/highlighted_journal/

Global: Zendy Plus annual

Presents the access of premium content as premium feature

Premium Content

Presents the keyphrase highlighting as premium feature

Keyphrase Highlighting

Presents the summarisation as premium feature

Summarisation

Insights

Presents the pdf analysis as premium feature

PDF Analysis

Presents the zaia usage as premium feature

ZAIA

Global: Zendy Plus monthly

Global: Zendy Tools annual

Global: Zendy Tools monthly

Global: Zendy Free Plan

Background Many studies on the genetic background of common neoplastic diseases indicate that they may be the result of hereditary mutations in cancer susceptibility genes, such as BRCA1, CHEK2, CDKN2A, NOD2, NBS1. The cancer occurrence in genetically predisposed mutation carriers may be a matter of life expectancy, efficiency of the immunological system, and cumulative action of toxic environmental agents. Most cytostatic drugs used in the treatment of cancers in oncological wards have mutagenic and carcinogenic activity. The exposure to them is difficult to avoid by the medical staff in their daily work during preparation and administration of drugs as well as during the contact with patients (physical examination, nursing care).

Constitutional mutations of cancer susceptibility genes in the health workers professionally exposed to cytostatic drugs